hotspot -WSS

hotspot

author：leisure time 2025-10-02 19:55:19 - browse：82836

People in business and medical wardrobe in a table discussion — coverage from STAT — Adobe

R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private.

Private equity firm New Mountain Capital has offered to purchase R1 for $13.75 per share, or roughly $5.8 billion in cash, according to new financial disclosures filed Monday. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares.

In response to the offer, R1 asked New Mountain Capital to “engage in good faith discussions” with its largest investor — a partnership between Ascension, the large Catholic hospital system, and private equity firm TowerBrook Capital Partners. New Mountain Capital has since held several in-person meetings with Ascension and TowerBrook throughout February, but maintained its original offer for R1. No deal has been finalized yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Peter Marks talks Operation Warp Speed for Rare Diseases

WSS

What the Wegovy shortage looks like for doctors — and for patients

WATCH: Why do our ears pop?

Life sciences deals on track to hit lowest point since 2017

How clinical AI models' predictive power can degrade over time

Hospitals are piloting generative AI tools as regulators play catch

WATCH: Why do our ears pop?

focus

hotspot

focus

Peter Hotez and the public health issue of online harassment

STAT Readout: Today's biotech news includes Sana and Amylyx

Trump demands the U.S. pay no more for drugs than other countries … again

Better Therapeutics data on benefit with GLP

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

The cancer drug shortage isn’t new — and neither are the solutions

Female surgeons have lower rates of long

hotspot

New study raises questions about niacin and heart health

There’s no way to know how good AI health technologies are

Humana CEO Bruce Broussard to step down in 2024

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

How should state employee insurance handle Wegovy?

Researchers CRISPR chickens in bid to protect them from bird flu

knowledge

focus

hotspot

hotspot